Prostate cancer drug firm sold to China’s Sanpower Group / ReutersCanada’s Valeant Pharmaceuticals International announced the sale for $819.9 million of its Seattle-based subsidiary Dendreon to Sanpower Group, a Chinese conglomerate with interests in real estate, health care, media, and finance. According to Sanpower’s press release, Dendreon’s “only commercialized product is Provenge, an immunotherapy treatment for prostate cancer treatment approved by the FDA in April 2010.” The new owner intends to increase sales in the U.S. and introduce Provenge to China and other Asian markets. SupChina recently noted that the incidence of prostate cancer among Chinese men is rising by 12 percent annually.

Jack Ma tells President-elect Trump that Alibaba can help create 1 million U.S. jobs/ SCMP U.S. president-elect Donald Trump met Alibaba executive Jack Ma at Trump Tower in New York City on Monday. Speaking to the press after the meeting, the two vowed to create 1 million new U.S. jobs through Alibaba’s ecommerce platform by helping small businesses and farmers sell products to Chinese and Southeast Asian consumers. “Trump’s meeting with Ma sends a positive signal,” commented Fu Mengzi, deputy director of China Institutes of Contemporary International Relations, a think tank closely associated with the Ministry of State Security.

Listen

‘Critical’ journalism in China, explained by Maria Repnikova

Outside observers typically view China’s media as utterly shackled by the bonds of censorship, unable to critique the government or speak truth to power in any meaningful sense. In part, this is true — censorship and other pressures do create “no-go” zones for journalists in China, as well as gray zones that sometimes rapidly turn […]

Michael Yamashita’s Photo of the Day

Rabbits in colorful cages for sale at a temple fair near Lianhuachi Park in Beijing in 2010 during the Spring Festival celebration. At these fairs, which are popular during this time of year, vendors sell food and sometimes pets.